Description

Premium Biomedical Material

Calcium-Deficient Hydroxyapatite (CDHA)

A bioactive, non-stoichiometric calcium phosphate powder engineered to chemically and structurally mimic the mineral phase of natural bone, delivering superior physiological solubility and osteoconductivity.

Product Overview

Calcium-Deficient Hydroxyapatite (CDHA) is a high-purity, bioactive crystalline powder. Characterized by a reduced calcium-to-phosphorus atomic ratio (1.50 < Ca/P < 1.67), its unique resorbable nature makes it a critical scaffold for bone tissue engineering, controlled drug delivery systems, and dental regenerative therapies. It is meticulously manufactured under a controlled environment via a wet chemical route.

Biomimetic composition structurally similar to natural human bone
Reduced Ca/P ratio ensures enhanced physiological resorbability
High specific surface area optimizes downstream biological responses
Manufactured via a precise wet chemical route in a controlled environment
Available in convenient 10 g and 100 g packaging for versatile scaling

Product Details

Product Name	Calcium-Deficient Hydroxyapatite (CDHA)
Chemical Formula	Ca_10-x(HPO₄)_x(PO₄)_6-x(OH)_2-x ; [0 < x < 1]
Molecular Weight	502.31 g/mol
CAS Number	12167-74-7
Appearance & Form	Milky White Powder
Crystal System	Hexagonal

Physical & Chemical Properties

Phase Identification	Conforms with ICDD file no. 09-0432
Atomic Ratio	1.50 < Ca/P < 1.67
Particle Size (Sieving)	< 75 µm
Particle Size Dist. (D10)	2 – 5 µm (DLS)
Particle Size Dist. (D50)	15 – 25 µm (DLS)
Particle Size Dist. (D90)	40 – 55 µm (DLS)
Bulk Density	0.2 – 0.8 g/cc

Key Features & Advantages

Exceptional Biocompatibility: Non-toxic material that seamlessly integrates with native biological tissues.
Controlled Resorbability: Breaks down predictably under physiological conditions to support natural bone remodeling.
High Phase Purity: Ensures consistent composition and limits unintended reactions in delicate clinical environments.
Chemical Stability: Remains highly stable and is classified as a non-hazardous biomaterial.
Reliable Scaling: Strict batch-to-batch consistency for dependable performance from R&D through to commercialization.

Why Choose Ceramat CDHA?

Closely mimics natural bone mineral structure for rapid physiological acceptance
Features an optimized, non-stoichiometric calcium-to-phosphate ratio
Manufactured under stringent, controlled quality standards
Perfectly tailored for critical biomedical, tissue engineering, and advanced dental applications

Applications

Bone grafts, bone void fillers, and tissue engineering scaffolds
Orthopedic implants and advanced biomedical coatings
Targeted and controlled drug delivery systems
Dental restorative materials and regenerative therapies
Functional biomaterial formulations for advanced R&D

Frequently Asked Questions

1. In which applications can CDHA be used?

CDHA is primarily used in bone grafts, bone void fillers, orthopedic and biomedical coatings, dental materials, functional biomaterial formulations, and specialized research and development projects.

2. What is the shelf-life of the product?

The product maintains a shelf-life of 3 Years from the date of manufacturing when stored correctly.

3. Why choose our manufacturing for CDHA?

Manufactured under rigorously controlled quality standards
Phase purity continuously verified through advanced XRD testing
Proven biocompatibility backed by available toxicological data
Safe to handle; not classified as hazardous under GHS
Comprehensive documentation (CoA, MSDS, technical specs) available on request

Looking for High-Quality CDHA for Your Application?

For technical inquiries, documentation requests, or to discuss bulk packaging options, please contact our specialists.

Email: sales@tsl-ceramat.com

Contact No: +91 8857861496

Reviews

There are no reviews yet.

Be the first to review “Calcium-Deficient Hydroxyapatite (CDHA)”